JP2024517335A5 - - Google Patents
Info
- Publication number
- JP2024517335A5 JP2024517335A5 JP2023570090A JP2023570090A JP2024517335A5 JP 2024517335 A5 JP2024517335 A5 JP 2024517335A5 JP 2023570090 A JP2023570090 A JP 2023570090A JP 2023570090 A JP2023570090 A JP 2023570090A JP 2024517335 A5 JP2024517335 A5 JP 2024517335A5
- Authority
- JP
- Japan
- Prior art keywords
- bupropion
- nicotine
- zonisamide
- administering
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163187001P | 2021-05-11 | 2021-05-11 | |
| US63/187,001 | 2021-05-11 | ||
| PCT/US2022/028504 WO2022240819A1 (en) | 2021-05-11 | 2022-05-10 | Combination treatment methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024517335A JP2024517335A (ja) | 2024-04-19 |
| JP2024517335A5 true JP2024517335A5 (enExample) | 2025-05-19 |
Family
ID=84028804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023570090A Pending JP2024517335A (ja) | 2021-05-11 | 2022-05-10 | 組合せ治療方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250073186A1 (enExample) |
| EP (1) | EP4337181A4 (enExample) |
| JP (1) | JP2024517335A (enExample) |
| CN (1) | CN117693335A (enExample) |
| AU (1) | AU2022273620A1 (enExample) |
| CA (1) | CA3218448A1 (enExample) |
| WO (1) | WO2022240819A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4593814A1 (en) * | 2022-09-26 | 2025-08-06 | Rose Research Center, LLC | Combination for use in a method of preventing weight gain |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE232384T1 (de) * | 1997-10-03 | 2003-02-15 | Cary Medical Corp | Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion |
| US20070212428A1 (en) * | 2004-06-04 | 2007-09-13 | Mood Management Sciences, Inc. | Methods and compositions for treating mood disorder |
| US7671094B2 (en) * | 2005-06-27 | 2010-03-02 | Biovail Laboratories International S.R.L. | Bupropion hydrobromide and therapeutic applications |
| KR20150082689A (ko) * | 2006-11-09 | 2015-07-15 | 오렉시젠 세러퓨틱스 인크. | 단위 용량 팩키지 |
-
2022
- 2022-05-10 JP JP2023570090A patent/JP2024517335A/ja active Pending
- 2022-05-10 CA CA3218448A patent/CA3218448A1/en active Pending
- 2022-05-10 US US18/559,872 patent/US20250073186A1/en active Pending
- 2022-05-10 AU AU2022273620A patent/AU2022273620A1/en active Pending
- 2022-05-10 WO PCT/US2022/028504 patent/WO2022240819A1/en not_active Ceased
- 2022-05-10 CN CN202280044354.9A patent/CN117693335A/zh active Pending
- 2022-05-10 EP EP22808167.5A patent/EP4337181A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003243074B2 (en) | A buffered, liquid nicotine composition for pulmonary administration | |
| Henningfield et al. | Pharmacotherapy for Nicotine Dependence 1 | |
| US7767698B2 (en) | Formulation and use thereof | |
| EP1019088B1 (en) | Composition for the treatment of nicotine addiction containing mecamylamine and bupropion | |
| JP2013520408A (ja) | ニコチン含有ソフトゼラチントローチ | |
| JP2023551426A (ja) | 急速注入組成物及び方法 | |
| Molander et al. | Reduction of tobacco withdrawal symptoms with a sublingual nicotine tablet: a placebo controlled study | |
| Glover et al. | A multicenter phase 3 trial of lobeline sulfate for smoking cessation | |
| Reus et al. | Varenicline: new treatment with efficacy in smoking cessation | |
| Stack | Smoking cessation: an overview of treatment options with a focus on varenicline | |
| PL196334B1 (pl) | Zastosowanie agonistów receptorów GABA B i ich farmaceutycznie dopuszczalnych pochodnych w terapii abstynencji nikotynowej u uzależnionych od nikotyny pacjentów | |
| US20100113453A1 (en) | Sublingual Formulations of D-Cycloserine and Methods of Using Same | |
| Frishman | Smoking cessation pharmacotherapy | |
| KR20020075795A (ko) | 흡연을 감소시키거나 또는 제거하는 방법 | |
| Bittoun | A combination nicotine replacement therapy (NRT) algorithm for hard-to-treat smokers | |
| Prignot | Pharmacological approach to smoking cessation | |
| US20250073186A1 (en) | Combination treatment methods | |
| HUE034190T2 (en) | Linaclitaxel for the treatment of chronic constipation | |
| RU2572720C1 (ru) | Комплексное антиникотиновое средство | |
| US3989823A (en) | Compositions for combating nicotinism in man | |
| AU1045695A (en) | Use of lobeline for the treatment of nicotine withdrawal | |
| WO1995011678A9 (en) | Use of nicotine substitutes for the treatment of nicotine withdrawal | |
| WO2024073334A1 (en) | Combination for use in a method of preventing weight gain | |
| KR20240022248A (ko) | 시린진을 포함하는 니코틴 중독 및 금단 증상의 예방, 개선 또는 치료용 조성물 | |
| TW574037B (en) | Nicotine addiction treatment |